Reference
Tang H, et al. Successful treatment with apatinib plus human endostatin for refractory recurrent advanced pulmonary carcinosarcoma: A case report. Journal of Thoracic Oncology 12 (Suppl. 2): S2367 abstr. PUB008, No. 11, Nov 2017. Available from: URL: https://doi.org/10.1016/j.jtho.2017.09.1871 [abstract] - China
Rights and permissions
About this article
Cite this article
Endostatin/rivoceranib. Reactions Weekly 1694, 186 (2018). https://doi.org/10.1007/s40278-018-43587-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43587-2